Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below averageSTERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services.
In the company’s own words · 10-K filed May 29, 2026 · SEC EDGAR
Business segments
Jun 2026 · $1.49BThe company’s own SEC segment disclosure.
- Healthcare$1.05B70%
- Applied Sterilization Technologies$297.6M20%
- Life Science$146.7M10%
STERIS plc (STE) reported revenue of $1.59B in Q4 2026 (quarter ended Mar 31, 2026), up 7.3% from the same quarter a year earlier. That came with a gross margin of 44% and net income of $220M (14% of revenue). For the full year FY2026, revenue was $5.94B (+8.7% year on year) and net income $782M. Its largest segment in Jun 2026 was Healthcare at $1.05B, 70% of the disclosed total, well ahead of Applied Sterilization Technologies at 20%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.